Replies to post #325761 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

boi

You are asking a lot in a short period of time. The financial community is only beginning to accept the death of the amyloid thesis, and now you are looking for adoption of a pan-CNS approach which has never been contemplated, let alone suggested.

At a minimum it will take knockout 2b/3 trial results by 2-73 across indications before you will see "wait . . . what?!"

Huh, the "One size fits all", "Tube sock" method of medical science recently shown by FDA CV-19 brilliance (look the other way) will have to wait.

I favor the nuclear option. We'll see. I would not want to be the one trying to explain this to the families of passed on CNS patients when this is over....AND IT WILL BE OVER.

Not only were they wrong about AMYLOID but they are REALLY WRONG NOW.

[falconer66a]

The turning point to come.

You are asking a lot in a short period of time. The financial community is only beginning to accept the death of the amyloid thesis, and now you are looking for adoption of a pan-CNS approach which has never been contemplated, let alone suggested.

Oh, the “financial community” is not too smart; unable to comprehend either Anavex science itself, or how it will play out therapeutically?

Let’s watch. When the Rett clinical trial results are released, they will show, conclusively, that blarcamesine is able to safely modulate, promote normalized neuron functions, by means or mechanisms belonging to no other company.

The “financial community” is not dumb. With the Rett results, they will very quickly learn the essential biology of the Anavex molecule and see its implications. It will be both a financial and medical technology turning point.